We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
GLOBE SCIENTIFIC, LLC

Dirui Industrial

DIRUI Industrial Co., Ltd provides laboratory equipment and clinical diagnostic reagents for the in-vitro diagnostic ... read more Featured Products: More products

Download Mobile App





DIRUI Exhibits Latest Lab Automation Technologies and Devices

By LabMedica International staff writers
Posted on 06 Feb 2024

DIRUI Industrial Co. More...

(Jilin Province, China) is presenting its latest lab automation technologies and devices at Medlab Middle East 2024, including its advanced analyzers for clinical chemistry, urine analysis, and hematology testing.

At Medlab Middle East 2024, DIRUI is showcasing the MUS-3600 urinalysis system featuring four formed element modules that incorporate two urine analysis modules, and has a throughput of up to 480 T/H (for hybrid). It allows up to 580 urine samples to be loaded at one time and features a friendly design with a one-key QC & calibration function. DIRUI is also showcasing the BF-7200 automatic hematology analysis system which can test for 29 parameters, 2 scattergrams and 2 histograms, 7 parameters, 1 scattergram, and 1 histogram. It has a maximum throughput of 480T/H/CBD+DIFF 4 modules and comes with the prompt function of pathology and morphology abnormality alarm.

At the DIRUI booth at Medlab Middle East 2024, visitors can experience the CS-T240Plus fully automated chemistry analyzer which is a powerful desktop device with a constant throughput of 240 tests/ hour and optional ISE throughput of 480 tests/ hour. It performs whole blood testing for HbA1c and delivers accurate results using low minimum reaction volume and saving reagents. The CS-T240Plus has a water consumption of only 3L per hour and features a water quality check function for reliable results.

Related Links:
DIRUI Industrial Co.


Gold Member
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Serological Pipet Controller
PIPETBOY GENIUS
New
Toxoplasma Gondii Test
Toxo IgG ELISA
New
Shaking Incubator
Corning LSE 71L
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more

Immunology

view channel
Image: The tip optofluidic immunoassay platform enables rapid, multiplexed antibody profiling using only 1 μL of fingertip blood (Photo courtesy of hLife, DOI:10.1016/j.hlife.2025.04.005)

POC Diagnostic Platform Performs Immune Analysis Using One Drop of Fingertip Blood

As new COVID-19 variants continue to emerge and individuals accumulate complex histories of vaccination and infection, there is an urgent need for diagnostic tools that can quickly and accurately assess... Read more

Pathology

view channel
Image: Microscopy image of invasive breast cancer cells degrading their underlying extracellular matrix (Photo courtesy of University of Turku)

Visualization Tool Illuminates Breast Cancer Cell Migration to Suggest New Treatment Avenues

Patients with breast cancer who progress from ductal carcinoma in situ (DCIS) to invasive ductal carcinoma (IDC) face a significantly worse prognosis, as metastatic disease remains incurable.... Read more

Technology

view channel
Image: The machine learning-based method delivers near-perfect survival estimates for PAC patients (Photo courtesy of Shutterstock)

AI Method Predicts Overall Survival Rate of Prostate Cancer Patients

Prostate adenocarcinoma (PAC) accounts for 99% of prostate cancer diagnoses and is the second most common cancer in men globally after skin cancer. With more than 3.3 million men in the United States diagnosed... Read more
MEDLAB 2024
Copyright © 2000-2025 Globetech Media. All rights reserved.